XNAS
WULF
Market cap6.78bUSD
Oct 08, Last price
13.65USD
1D
-5.21%
1Q
-37.87%
Jan 2017
21.33%
Name
Ikonics Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
IKONICS Corporation, a company based in Duluth, Minnesota, specializes in the creation, production, and distribution of photochemical imaging solutions. The firm employs 75 full-time individuals and manages its operations through five distinct segments. The Domestic segment supplies distributors in the United States and Canada with screen printing film, emulsions, and inkjet receptive films. The Export segment primarily sells similar products internationally, alongside certain IKONICS Imaging products that are not part of the AMS or DTX divisions. IKONICS Imaging provides photo resistant film, art supplies, glass, metal medium, and related abrasive etching equipment. The Digital Texturing (DTX) segment focuses on inkjet technology for mold texturing and prototyping. Lastly, Advanced Material Solutions (AMS) delivers sound deadening technology for the aerospace industry, as well as products and services for etching composites, ceramics, glass, and silicon wafers.
Key people
William C. Ulland
Chairman of the Board · since 2020
Glenn Sandgren
President, Chief Executive Officer, Director · since 2020
Kenneth Hegman
Chief Operating Officer · since 2017
Claude P. Piguet
Executive Vice President · since 2000
Jon Gerlach
Chief Financial Officer, Vice President - Finance, Secretary · since 2003
Robert D. Banks
Vice President - International Sales · since 1997
Lockwood W. Carlson
Independent Director · since 2009
Ernest M. Harper
Independent Director · since 2012
David O. Harris
Independent Director · since 1965
Darrell B. Lee
Independent Director · since 2012
Gerald W. Simonson
Independent Director · since 1978
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2021‑03 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||